Study to Compare Vinorelbine In Combination With the mTOR Inhibitor Everolimus vs. Vinorelbin Monotherapy for Second-line Treatment in Advanced Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Her2-negative Metastatic Breast Cancer|Her2-negative Locally Advanced Breast Cancer
Interventions: DRUG: Vinorebine, Everolimus|DRUG: Vinorelbine
Sponsor: AIO-Studien-gGmbH
Collaborators: iOMEDICO AG|Novartis Pharmaceuticals